By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sales of women's health products helped drive Myriad Genetics' total revenues up 8 percent in the company's fiscal first quarter for 2011, but short of analysts' estimates.

For the three months ended Sept. 30, total revenues increased to $91.9 million, compared to $85.1 million a year ago, helped by an 18 percent jump in revenues related to woman's health products to $25.8 million from $21.8 million, the company reported after the close of market on Tuesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.